We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Glenn Saldanha, CMD, Glenmark Pharmaceuticals has taken over as the President of IPA for 2017-19. Rajesh Jain, Joint MD, Panacea Biotec has been appointed as the VP.